Related Experiment Video
Updated: Jun 3, 2026
07:14
Acupuncture in a Rat Model of Asthma
Published on: August 25, 2020
Controversial data on simvastatin in asthma: What about the rat model?
Thomas Tschernig1, Wolfgang Bäumer, Reinhard Pabst
1Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover.
Journal of Asthma and Allergy
|March 26, 2011
Summary
Simvastatin showed limited effects on lung inflammation in a rat asthma model, partially reducing immune cells but significantly impacting CD4 T cells. Results suggest species-specific responses, cautioning against human extrapolation.
Area of Science:
- Pulmonary Medicine
- Immunology
- Pharmacology
Background:
- Asthma treatment efficacy of simvastatin is debated, with conflicting results from animal models and human clinical studies.
- Murine models suggest anti-inflammatory effects, while human trials show no benefit.
- The rat asthma model offers unique advantages and is frequently used in research.
Purpose of the Study:
- To investigate the effects of simvastatin on lung inflammation in a rat model of asthma.
- To evaluate simvastatin's impact via intraperitoneal and intratracheal administration routes.
- To determine dose-dependent effects of simvastatin on inflammatory cell populations.
Main Methods:
- Utilized a rat model of asthma.
- Administered simvastatin via intraperitoneal and intratracheal routes at varying dosages (0.1, 1.0, 10 mg/animal).
- Quantified relative and absolute numbers of neutrophils, eosinophils, lymphocytes, and CD4 T cells.
Main Results:
- Simvastatin partially reduced neutrophils, eosinophils, and lymphocytes across tested dosages and administration routes.
- A significant reduction in CD4 T cell numbers was observed in most simvastatin-treated groups.
- The effects of simvastatin were dose-dependent, with partial efficacy noted.
Conclusions:
- Simvastatin exhibits species-specific effects on lung inflammation in asthma models.
- Current findings in rats do not support extrapolation to human asthma patients.
- Further research is needed to clarify simvastatin's role in human asthma.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.